Relenza Générique est utilisé pour traiter les symptômes de la grippe causée par le virus influenza chez les patients qui ont des symptômes depuis moins de 2 jours. Ce médicament peut également être administré afin de prévenir l'influenza chez les gens qui peuvent y être exposé mais qui ne montrent pas de symptômes. Ce médicament ne traite pas le rhume.
Liquidia touts promise of next-gen respiratory delivery - FierceDrugDelivery
Liquidia touts promise of next-gen respiratory deliveryFierceDrugDeliveryIn one study, researchers took the API zanamivir and crafted a molecule with PRINT.
Study: H1N1 resistance to oseltamivir may spread - CIDRAP
Study: H1N1 resistance to oseltamivir may spreadCIDRAP.
Ready, set, trial: why pandemics catch us out and how to prepare for them - Discover Magazine (blog)
Discover Magazine (blog)Ready, set, trial: why pandemics catch us out and how to prepare for themDiscover Magazine (blog)Tamiflu's relatives, zanamivir and peramivir, are similarly mysterious.
Theraclone Passes First Clinical Test with Flu-Fighting Antibody - Xconomy
XconomyTheraclone Passes First Clinical Test with Flu-Fighting AntibodyXconomyWhile there are already a couple of antiviral pills on the market—Roche's oseltamivir phosphate (Tamiflu) or GlaxoSmithKline's zanamivir (Relenza)—scientists worry about mutant strains like H5N1 “bird flu” that could emerge and resist today's .
Biota Announces Inavir(R) Royalty Results for Q312 and Phase III Prevention ... - MarketWatch (press release)
Biota Announces Inavir(R) Royalty Results for Q312 and Phase III Prevention .